New York, NY UNS: NYC Health + Hospitals has received top national recognition from the American Heart Association (AHA) for its excellence in managing high blood pressure, type 2 diabetes, and cholesterol, three major risk factors for heart attack and stroke.
Twenty-one primary care sites earned the 2026 Target: BP Gold+ award, the AHA’s highest recognition for blood pressure management. The award acknowledges facilities that achieved blood pressure control in at least 70% of their patients.
Additionally, 23 primary care sites received the 2026 Target: Type 2 Diabetes Gold award for meeting high standards in diabetes control, cardiovascular risk reduction, hypertension, and cholesterol management.
The same 23 sites also earned the 2026 Check. Change. Control. Cholesterol Gold award for ensuring that at least 70% of adult patients at risk of cardiovascular disease received statin therapy.
Nichola Davis, MD, MS, Vice President and Chief Population Health Officer at NYC Health + Hospitals, highlighted the health system’s extensive programs, resources, and staff training initiatives focused on chronic disease prevention and management. She said the recognition reflects the system’s commitment to improving patient outcomes and saving lives.
Andrew Wallach, MD, Chief Medical Officer of Ambulatory Care, emphasized the importance of screening, early diagnosis, and connecting patients with primary care for effective chronic disease management.
Michelle Lewis, CEO of NYC Health + Hospitals/Gotham Health, praised the dedication of care teams in providing accessible, high-quality services and preventing serious complications.
The recognition underscores NYC Health + Hospitals’ continued commitment to advancing cardiovascular health and improving the well-being of communities across New York City.
